Stage Revenue; commercial sales in 9 countries
Investors The Trendlines Group; B. Braun
CEO Paul Mraz
The minimally invasive ApiFix system incorporates a miniature ratchet mechanism that captures incremental corrections performed by the patient according to the physical therapy regimen. The deformity correction process spans several months to allow the soft tissues to accommodate any minor correction. The ApiFix system is inserted through a small incision in the patient’s back and uses only two screws to support its ratchet-based, small expandable rod.
Newly issued patent, bringing total to 20 issued patents; 7 active patent families (issued and pending)
Surpassed 275 patients and achieved 6-year follow up of earliest treated patients
Completed first surgical procedures in North America and Singapore
Certification: CE mark
Targeted sales: Europe, Canada, Asia
Distribution agreements: Canada, Spain, Holland, Greece, Singapore
Offices: Boston, Massachusetts, and Misgav, Israel
Founder Dr. Yizhar Floman on ILTV
Founder Uri Arnin presents ApiFix
ApiFix on Israel's Health Channel program, Only Health
25+ years of spine and orthopedic medical device experience; senior/executive-level positions in U.S.- and Israel-based companies, including management, corporate strategy, product development and marketing, sales management — all on a global basis
CEO of Ellipse Technologies from 2011 to 2016, when it was acquired by NuVasive for $410 million
More than 10 years of experience in the spine field; inventor and CTO, Impliant Inc.; founder and CTO, Spine21 Ltd.
Spine surgeon; president of the Israeli Spine Society
Today’s gold standard for correcting spinal deformities involves fusing an average of 10 motion levels using a large number of screws in a surgical procedure that lasts an average of six hours and costs upward of $100,000. Worldwide, there are approximately 126,000 scoliosis procedures per year, of which 40,000 are AIS, representing a $2.4 billion implant market.* The cost of scoliosis correction implants in the United States, not including hospitalization, is around $600 million annually, with an estimated $300 million market outside the United States.
*U.S. National Center for Health Statistics; OECD Health Data 2015; Statistique annuelle des établissements de santé and CNAMTS (Evolution des actes techniques en secteur liberal); Statistisches Bundesamt; Conjunto Mínimo Básico de Datos – Hospitalización and Ambulatorio; UK Hospital Episode Statistics databases for Admitted Patient Care and Outpatients; Life Science Intelligence Surgical Procedure Volume database.